Action for child survival: elimination of Haemophilus influenzae type b meningitis in Uganda
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To guide immunization policy, we determined the public health benefit of introducing Haemophilus influenzae type b (Hib) vaccine in Uganda and estimated the vaccine effectiveness. METHODS: Surveillance data for acute bacterial meningitis among children aged 0-59 months were reviewed from three hospital sentinel sites, for July 2001 to June 2007, to determine the incidence of Hib meningitis, the effectiveness of Hib vaccine with a case-control design, and the number of vaccine-preventable cases and deaths of Hib disease in Uganda. FINDINGS: Of the 13 978 children from 17 districts with suspected bacterial meningitis, 269 had confirmed Hib meningitis, declining from 69 patients in the prevaccine year (2001-2002) to three in 2006-2007. Hib meningitis incidence dropped from 88 cases per 100,000 children aged < 5 years in the year before vaccine introduction to 13 within 4 years, and to near zero in the fifth year. Vaccine effectiveness for 2 or more doses was 93% (95% confidence interval, CI: 69-99) against confirmed Hib meningitis and 53% (95% CI: 11-68) against purulent meningitis of unknown cause. In Uganda, Hib vaccine prevents an estimated 28 000 cases of pneumonia and meningitis, 5000 deaths and 1000 severe meningitis sequelae each year. CONCLUSION: Infant immunization with Hib vaccine has virtually eliminated Hib meningitis in Uganda within 5 years. Ensuring long-term benefits of Hib vaccine urgently requires sustainable vaccine financing, high-quality ongoing surveillance, and a health sector able to deliver a robust immunization programme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era
Adams, W. G. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500020055031 · Cited by 696
Adegbola, R. A., Secka, O., Lahai, G., Lloyd-Evans, N., Njie, A., Usen, S., Oluwalana, C., Obaro, S., Weber, M., Corrah, T., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66788-8 · Cited by 286
Cowgill, K. D., Ndiritu, M., Nyiro, J., Slack, M. P. E., Chiphatsi, S., Ismail, A., Kamau, T., Mwangi, I., English, M., Newton, C. R. J. C., et al. (2006) · JAMA · doi:10.1001/jama.296.6.671 · Cited by 183
WENGER, J. D. (1998) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199809001-00008 · Cited by 153
Daza, P., Banda, R., Misoya, K., Katsulukuta, A., Gessner, B. D., Katsande, R., Mhlanga, B. R., Mueller, J. E., Nelson, C. B., Phiri, A., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.076 · Cited by 71
Effectiveness of vaccination for Haemophilus influenzae type b
Garner, D., & Weston, V. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12385-9 · Cited by 51
Rapid Assessment Tool for Haemophilus influenzae type b Disease in Developing Countries1
Feikin, D. R., Nelson, C. B., Watt, J. P., Mohsni, E., Wenger, J. D., & Levine, O. S. (2004) · Emerging infectious diseases · doi:10.3201/eid1007.030737 · Cited by 45
Cited by
Watt, J. P., Wolfson, L. J., O'Brien, K. L., Henkle, E., Deloria-Knoll, M., McCall, N., Lee, E., Levine, O. S., Hajjeh, R., Mulholland, K., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61203-4 · Cited by 501
Verani, J. R., Baqui, A. H., Broome, C. V., Cherian, T., Cohen, C., Farrar, J. L., Feikin, D. R., Groome, M. J., Hajjeh, R. A., Johnson, H. L., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.04.037 · Cited by 102
“Examples of this approach include: rotavirus-negative gastroenteritis as controls for cases of rotavirus [36,41,43], influenza-negative respiratory infection for cases of influenza [71], pneumococcal or non-purulent/ Hib-negative meningitis as controls for Hib meningitis cases [18,20], and non-vaccine serotype invasiv…”
BackgroundPage, A.-L., Boum II, Y., Kemigisha, E., Salez, N., Nanjebe, D., Langendorf, C., Aberrane, S., Nyehangane, D., Nackers, F., Baron, E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02741-w · Cited by 18
Metadata
- Authors
- Lewis, R.
- Venue
- Bulletin of the World Health Organization
- Publisher
- WHO Press
- Published
- 2008-04-01
- Volume
- 86
- Issue
- 4
- Pages
- 292-301
- ISSN
- 0042-9686 (ISSN-L)
- OpenAlex
- W2133719475
- Cited by
- 64
- References
- 7
- FWCI
- 8.67
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.